RxLink Partners with Cost Plus Drugs to Deliver Affordable Medications to Patients

RxLink, a firm dedicated to ensuring transparency in prescription medication pricing, shares the same commitment as Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), and is excited to announce a new partnership. This collaboration aims to provide patients from top health systems with access to Cost Plus Drugs' selection of safe medications at the most competitive prices possible. Leveraging the innovative RxLink MedMap™, which automatically considers a patient's insurance, third-party discount cards, and manufacturer offers, this initiative ensures comprehensive coverage checks and delivers the lowest-cost recommendations for each medication to patients via SMS and a user-friendly web portal. Since incorporating Cost Plus Drugs into the MedMap™, RxLink has already identified and facilitated over $162,000 in patient savings within just three months.